U.S. to donate 500 million Pfizer doses to poor nations | Inquirer
 
 
 
 
 
 

U.S. to donate 500 million Pfizer doses to poor nations

/ 08:58 AM June 10, 2021

 Empty vials of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen at The Michener Institute, in Toronto, Canada January 4, 2021. REUTERS/Carlos Osorio/File Photo

Empty vials of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine are seen at The Michener Institute, in Toronto, Canada January 4, 2021. REUTERS/Carlos Osorio/File Photo

The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.

The vaccine donation – the largest ever by a single country – was announced before U.S. President Joe Biden meets leaders of the Group of Seven advanced economies in western England.

ADVERTISEMENT

The 500 million doses are destined for the world’s 100 poorest countries. A senior Biden administration official described the gesture as a “major step forward that will supercharge the global effort” with the aim of “bringing hope to every corner of the world.” “We really want to underscore that this is fundamentally about a singular objective of saving lives,” the official said, adding that Washington was not seeking favours in exchange for the doses.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

The Biden administration expects other G7 members to come up with contributions as part of a comprehensive road map to end a pandemic that has killed more than 3.9 million people, the official added.

U.S. drugmaker Pfizer and its German partner BioNTech had earlier said they would provide 200 million doses in 2021 and 300 million doses in the first half of 2022.

The shots, which will be produced at Pfizer’s U.S. sites, will be supplied at a not-for-profit price.

“Our partnership with the U.S. government will help bring hundreds of millions of doses of our vaccine to the poorest countries around the world as quickly as possible,” said Pfizer Chief Executive Albert Bourla.

‘DROP IN THE BUCKET’

Anti-poverty campaign group Oxfam called for more to be done to increase global production of vaccines.

ADVERTISEMENT

“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that’s still a drop in the bucket compared to the need across the world,” said Niko Lusiani, Oxfam America’s vaccine lead.

“We need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints,” he added in a statement.

Biden has backed calls for a waiver of some vaccine intellectual property rights but there is no international consensus on how to proceed.

The new donations come on top of 80 million doses Washington has already pledged to donate by the end of June, and $2 billion in funding earmarked for the COVAX program led by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), the White House said.

GAVI and the WHO welcomed the initiative.

Washington is also taking steps to support local production of COVID-19 vaccines in other countries, including through its Quad initiative with Japan, India and Australia.

Biden’s announcement comes amid mounting pressure for the United States, which has now given at least one shot to around 64% of its adult population, to boost donations of vaccines to other countries in desperate need.

(Reporting by Steve Holland in St. Ives, England, Andrea Shalal in Washington and Caroline Copley in Berlin; Writing by Guy Faulconbridge and Keith Weir; Editing by Leslie Adler, David Evans, Emelia Sithole-Matarise and Giles Elgood)

MORE STORIES
Don't miss out on the latest news and information.
TAGS: Covid vaccine
For feedback, complaints, or inquiries, contact us.
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.




We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.